Dr. Bear is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
705 Riley Hospital Dr
# Roc
Indianapolis, IN 46202Phone+1 317-944-5611Fax+1 317-944-3107
Education & Training
Indiana University School of MedicineMSc, Clinical Research, 2008 - 2012
Indiana University School of MedicineFellowship, Pediatric Hematology/Oncology, 2007 - 2010- Indiana University School of MedicineResidency, Pediatrics, 2004 - 2007
Pennsylvania State University College of MedicineClass of 2004
Certifications & Licensure
IN State Medical License 2005 - 2025- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Study of Tasigna®/Nilotinib (AMN107) in Neurofibromatosis (NF1) Patients With Plexiform Neurofibromas Start of enrollment: 2011 Jan 01
Publications & Presentations
PubMed
- 73 citationsA Phase II Study of Abemaciclib in Patients with Brain Metastases Secondary to Hormone Receptor-Positive Breast Cancer.Sara M Tolaney, Solmaz Sahebjam, Emilie Le Rhun, Thomas Bachelot, Peter Kabos
Clinical Cancer Research. 2020-10-15 - 12 citationsOutpatient administration of naxitamab in combination with granulocyte-macrophage colony-stimulating factor in patients with refractory and/or relapsed high-risk neuro...Jaume Mora, Godfrey C Chan, Daniel A Morgenstern, Karsten Nysom, Melissa K Bear
Cancer Reports. 2023-01-01 - 12 citationsClinical activity of abemaciclib in patients with relapsed or refractory mantle cell lymphoma - a phase II study.Franck Morschhauser, Kamal Bouabdallah, Stephan Stilgenbauer, Catherine Thieblemont, Sophie de Guibert
Haematologica. 2020-05-07
Journal Articles
- A Standardized autopsy procurement allow for the comprehensive study of DIPG biologyMadhuri Kambhampati,Jennifer P Perez,Sridevi Yadavilli, Amanda M. Saratsis,Ashley D. Hill, Cheng-Ying Ho, Eshini Panditharatna,Melissa Markel, Roger J. Packer,Javad N..., Oncotarget, 5/2015
Abstracts/Posters
- A phase 2 study of abemaciclib in patients with leptomeningeal metastases secondary to HR+, HER2- breast cancer [abstract]. In: Proceedings of the 2018 San Antonio Bre...Tolaney SM, Sahebjam S, Le Rhun E, Lin NU, Markel Bear M, Yang Z, Chen Y, Anders CK, Proceedings of the 2018 San Antonio Breast Cancer Symposium;, 12/2018
- nextMONARCH 1: Phase 2 study of abemaciclib plus tamoxifen or abemaciclib alone in HR+, HER2- advanced breast cancer [abstract].Hamilton E, Cortes J, Dieras V, Ozyilkan O, Chen S-C, Petrakova K, Manikhas A, Jerusalem G, Hegg R, Lu Y, Bear MM, Johnston EL, Martin M, In: Proceedings of the 2018 San Antonio Breast Cancer Symposium;, 12/2018
- Examining Urinary Biomarkers of Cisplatin Nephrotoxicity in Children.Markel M, Ross J, Then J, Renbarger J., Pediatric Blood and Cancer., ASPHO, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
